Five of Five VHHs Neutralizing Poliovirus Bind the Receptor-Binding Site

Journal of Virology
Mike StraussJ M Hogle

Abstract

Nanobodies, or VHHs, that recognize poliovirus type 1 have previously been selected and characterized as candidates for antiviral agents or reagents for standardization of vaccine quality control. In this study, we present high-resolution cryo-electron microscopy reconstructions of poliovirus with five neutralizing VHHs. All VHHs bind the capsid in the canyon at sites that extensively overlap the poliovirus receptor-binding site. In contrast, the interaction involves a unique (and surprisingly extensive) surface for each of the five VHHs. Five regions of the capsid were found to participate in binding with all five VHHs. Four of these five regions are known to alter during the expansion of the capsid associated with viral entry. Interestingly, binding of one of the VHHs, PVSS21E, resulted in significant changes of the capsid structure and thus seems to trap the virus in an early stage of expansion. We describe the cryo-electron microscopy structures of complexes of five neutralizing VHHs with the Mahoney strain of type 1 poliovirus at resolutions ranging from 3.8 to 6.3Å. All five VHHs bind deep in the virus canyon at similar sites that overlap extensively with the binding site for the receptor (CD155). The binding surfaces on ...Continue Reading

References

Jun 3, 1993·Nature·C Hamers-CastermanR Hamers
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M BelnapA C Steven
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·K E ConrathS Muyldermans
Mar 29, 2003·Journal of Virology·Yongning HeMichael G Rossmann
Apr 15, 2003·Journal of Virology·Pranav DanthiMarie Chow
Jun 5, 2003·Journal of Structural Biology·Joseph A Mindell, Nikolaus Grigorieff
Mar 1, 1962·The Journal of Hygiene·A J BEALE, P J MASON
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
May 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yumin LiCarol Beth Post
Jul 11, 2006·Journal of Structural Biology·Nikolaus Grigorieff
Jul 25, 2006·Journal of Structural Biology·Guang TangSteven J Ludtke
Jul 12, 2007·PLoS Biology·Boerries BrandenburgJames M Hogle
Jun 23, 2010·Antiviral Research·Bert ThysBart Rombaut
Mar 6, 2012·Nature Structural & Molecular Biology·Xiangxi WangZihe Rao
Jul 31, 2012·Nature Methods·Sjors H W Scheres, Shaoxia Chen
Sep 25, 2012·Journal of Structural Biology·Sjors H W Scheres
Jun 4, 2013·Nature Communications·Jingshan RenElizabeth E Fry
Apr 16, 2015·Human Vaccines & Immunotherapeutics·Nagendra R Hegde
May 28, 2015·Antimicrobial Agents and Chemotherapy·Lise SchotteJames M Hogle

❮ Previous
Next ❯

Citations

Jan 13, 2018·Frontiers in Immunology·Yanling WuTianlei Ying
Jan 14, 2020·Journal of Molecular Biology·Michael J RudolphNicholas J Mantis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.